Reduced expression and defective modulation of TNF receptor/ligand family molecules on proB-ALL blasts

Anja Troeger, L. Glouchkova, G. Escherich, M. Siepermann, H. Hanenberg, G. Janka-Schaub, U. Göbel, B. Ackermann, D. Dilloo

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background: There is a subgroup of pediatric patients with an immature immunophenotype of proB-ALL that still poses a therapeutic challenge, even if the overall prognosis in B cell precursor acute lymphoblasic leukemia (BCP-ALL) is very good. Due to impaired treatment response these patients are prone to suffer relapse and are thus by definition stratified into the clinically defined high risk group receiving intensified chemotherapy. Besides response to chemotherapy long term prognosis is also influenced by immunological control mechanisms. Thus, high expression of the TNF receptor CD40 has been shown to prevent particularly late relapse in BCP-ALL suggesting a pivotal role of this regulatory molecule for maintenance of the remission status. Patients and methods: We therefore determined the baseline expression and CD40-mediated modulation of TNF receptor and costimulatory molecules in 5 patients with proB-ALL, 8 with preB-ALL and 22 with c-ALL performing FACS analysis. We particularly compared the TNF receptor status on proB-ALL blasts to the expression on more mature preB- and c-ALL blasts. Results: Here, we demonstrate for the first time a significantly lower baseline expression and CD40-induced modulation capacity of TNF receptor and costimulatory molecules in pediatric proB-ALL compared to more mature precursor B-ALL blasts. Conclusion: The lower expression and defective capacity of proB-ALL blasts to respond to CD40 ligand stimulation might resemble the immature feature of these blasts and besides increased chemoresistance contribute to the impaired prognosis of these patients due to escape from apoptosis and immunological control mechanisms.

Original languageEnglish (US)
Pages (from-to)353-357
Number of pages5
JournalKlinische Padiatrie
Volume220
Issue number6
DOIs
StatePublished - Nov 2008
Externally publishedYes

Fingerprint

Tumor Necrosis Factors
Tumor Necrosis Factor Receptors
B-Lymphoid Precursor Cells
Leukemia
Pediatrics
Recurrence
Drug Therapy
CD40 Ligand
Maintenance
Apoptosis
Therapeutics

Keywords

  • Pediatrics
  • ProB-ALL
  • TNF receptors

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Troeger, A., Glouchkova, L., Escherich, G., Siepermann, M., Hanenberg, H., Janka-Schaub, G., ... Dilloo, D. (2008). Reduced expression and defective modulation of TNF receptor/ligand family molecules on proB-ALL blasts. Klinische Padiatrie, 220(6), 353-357. https://doi.org/10.1055/s-0028-1086028

Reduced expression and defective modulation of TNF receptor/ligand family molecules on proB-ALL blasts. / Troeger, Anja; Glouchkova, L.; Escherich, G.; Siepermann, M.; Hanenberg, H.; Janka-Schaub, G.; Göbel, U.; Ackermann, B.; Dilloo, D.

In: Klinische Padiatrie, Vol. 220, No. 6, 11.2008, p. 353-357.

Research output: Contribution to journalArticle

Troeger, A, Glouchkova, L, Escherich, G, Siepermann, M, Hanenberg, H, Janka-Schaub, G, Göbel, U, Ackermann, B & Dilloo, D 2008, 'Reduced expression and defective modulation of TNF receptor/ligand family molecules on proB-ALL blasts', Klinische Padiatrie, vol. 220, no. 6, pp. 353-357. https://doi.org/10.1055/s-0028-1086028
Troeger A, Glouchkova L, Escherich G, Siepermann M, Hanenberg H, Janka-Schaub G et al. Reduced expression and defective modulation of TNF receptor/ligand family molecules on proB-ALL blasts. Klinische Padiatrie. 2008 Nov;220(6):353-357. https://doi.org/10.1055/s-0028-1086028
Troeger, Anja ; Glouchkova, L. ; Escherich, G. ; Siepermann, M. ; Hanenberg, H. ; Janka-Schaub, G. ; Göbel, U. ; Ackermann, B. ; Dilloo, D. / Reduced expression and defective modulation of TNF receptor/ligand family molecules on proB-ALL blasts. In: Klinische Padiatrie. 2008 ; Vol. 220, No. 6. pp. 353-357.
@article{cb83a41086d14bd183e2b6365aa68cfa,
title = "Reduced expression and defective modulation of TNF receptor/ligand family molecules on proB-ALL blasts",
abstract = "Background: There is a subgroup of pediatric patients with an immature immunophenotype of proB-ALL that still poses a therapeutic challenge, even if the overall prognosis in B cell precursor acute lymphoblasic leukemia (BCP-ALL) is very good. Due to impaired treatment response these patients are prone to suffer relapse and are thus by definition stratified into the clinically defined high risk group receiving intensified chemotherapy. Besides response to chemotherapy long term prognosis is also influenced by immunological control mechanisms. Thus, high expression of the TNF receptor CD40 has been shown to prevent particularly late relapse in BCP-ALL suggesting a pivotal role of this regulatory molecule for maintenance of the remission status. Patients and methods: We therefore determined the baseline expression and CD40-mediated modulation of TNF receptor and costimulatory molecules in 5 patients with proB-ALL, 8 with preB-ALL and 22 with c-ALL performing FACS analysis. We particularly compared the TNF receptor status on proB-ALL blasts to the expression on more mature preB- and c-ALL blasts. Results: Here, we demonstrate for the first time a significantly lower baseline expression and CD40-induced modulation capacity of TNF receptor and costimulatory molecules in pediatric proB-ALL compared to more mature precursor B-ALL blasts. Conclusion: The lower expression and defective capacity of proB-ALL blasts to respond to CD40 ligand stimulation might resemble the immature feature of these blasts and besides increased chemoresistance contribute to the impaired prognosis of these patients due to escape from apoptosis and immunological control mechanisms.",
keywords = "Pediatrics, ProB-ALL, TNF receptors",
author = "Anja Troeger and L. Glouchkova and G. Escherich and M. Siepermann and H. Hanenberg and G. Janka-Schaub and U. G{\"o}bel and B. Ackermann and D. Dilloo",
year = "2008",
month = "11",
doi = "10.1055/s-0028-1086028",
language = "English (US)",
volume = "220",
pages = "353--357",
journal = "Klinische Padiatrie",
issn = "0300-8630",
publisher = "Georg Thieme Verlag",
number = "6",

}

TY - JOUR

T1 - Reduced expression and defective modulation of TNF receptor/ligand family molecules on proB-ALL blasts

AU - Troeger, Anja

AU - Glouchkova, L.

AU - Escherich, G.

AU - Siepermann, M.

AU - Hanenberg, H.

AU - Janka-Schaub, G.

AU - Göbel, U.

AU - Ackermann, B.

AU - Dilloo, D.

PY - 2008/11

Y1 - 2008/11

N2 - Background: There is a subgroup of pediatric patients with an immature immunophenotype of proB-ALL that still poses a therapeutic challenge, even if the overall prognosis in B cell precursor acute lymphoblasic leukemia (BCP-ALL) is very good. Due to impaired treatment response these patients are prone to suffer relapse and are thus by definition stratified into the clinically defined high risk group receiving intensified chemotherapy. Besides response to chemotherapy long term prognosis is also influenced by immunological control mechanisms. Thus, high expression of the TNF receptor CD40 has been shown to prevent particularly late relapse in BCP-ALL suggesting a pivotal role of this regulatory molecule for maintenance of the remission status. Patients and methods: We therefore determined the baseline expression and CD40-mediated modulation of TNF receptor and costimulatory molecules in 5 patients with proB-ALL, 8 with preB-ALL and 22 with c-ALL performing FACS analysis. We particularly compared the TNF receptor status on proB-ALL blasts to the expression on more mature preB- and c-ALL blasts. Results: Here, we demonstrate for the first time a significantly lower baseline expression and CD40-induced modulation capacity of TNF receptor and costimulatory molecules in pediatric proB-ALL compared to more mature precursor B-ALL blasts. Conclusion: The lower expression and defective capacity of proB-ALL blasts to respond to CD40 ligand stimulation might resemble the immature feature of these blasts and besides increased chemoresistance contribute to the impaired prognosis of these patients due to escape from apoptosis and immunological control mechanisms.

AB - Background: There is a subgroup of pediatric patients with an immature immunophenotype of proB-ALL that still poses a therapeutic challenge, even if the overall prognosis in B cell precursor acute lymphoblasic leukemia (BCP-ALL) is very good. Due to impaired treatment response these patients are prone to suffer relapse and are thus by definition stratified into the clinically defined high risk group receiving intensified chemotherapy. Besides response to chemotherapy long term prognosis is also influenced by immunological control mechanisms. Thus, high expression of the TNF receptor CD40 has been shown to prevent particularly late relapse in BCP-ALL suggesting a pivotal role of this regulatory molecule for maintenance of the remission status. Patients and methods: We therefore determined the baseline expression and CD40-mediated modulation of TNF receptor and costimulatory molecules in 5 patients with proB-ALL, 8 with preB-ALL and 22 with c-ALL performing FACS analysis. We particularly compared the TNF receptor status on proB-ALL blasts to the expression on more mature preB- and c-ALL blasts. Results: Here, we demonstrate for the first time a significantly lower baseline expression and CD40-induced modulation capacity of TNF receptor and costimulatory molecules in pediatric proB-ALL compared to more mature precursor B-ALL blasts. Conclusion: The lower expression and defective capacity of proB-ALL blasts to respond to CD40 ligand stimulation might resemble the immature feature of these blasts and besides increased chemoresistance contribute to the impaired prognosis of these patients due to escape from apoptosis and immunological control mechanisms.

KW - Pediatrics

KW - ProB-ALL

KW - TNF receptors

UR - http://www.scopus.com/inward/record.url?scp=56349088823&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=56349088823&partnerID=8YFLogxK

U2 - 10.1055/s-0028-1086028

DO - 10.1055/s-0028-1086028

M3 - Article

C2 - 18949670

AN - SCOPUS:56349088823

VL - 220

SP - 353

EP - 357

JO - Klinische Padiatrie

JF - Klinische Padiatrie

SN - 0300-8630

IS - 6

ER -